Fidelity Investments’s Silence Therapeutics SLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.5M Buy
+4,710,812
New +$57.3M ﹤0.01% 1488

Other funds holding SLN

Fidelity Investments's SLN Position: Q3 2026 in Review

Fidelity Investments opened a new position in Silence Therapeutics (SLN) in Q3 2026: 4,710,812 shares worth $51.5M. The stake represents ﹤0.01% of the portfolio and ranks #1488 among its holdings.

92 funds tracked by Wall St. Rank hold SLN as of Q3 2026.

  • Fidelity Investments held 4,710,812 shares of Silence Therapeutics worth $51.5M as of Q3 2026.
  • Silence Therapeutics was a new Fidelity Investments position in Q3 2026.
  • Silence Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1488 holding.
  • 92 funds tracked by Wall St. Rank held Silence Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.